scispace - formally typeset
S

Sakineh Dadashpour

Researcher at Mazandaran University of Medical Sciences

Publications -  8
Citations -  641

Sakineh Dadashpour is an academic researcher from Mazandaran University of Medical Sciences. The author has contributed to research in topics: Receptor tyrosine kinase & Prodrug. The author has an hindex of 6, co-authored 7 publications receiving 452 citations.

Papers
More filters
Journal ArticleDOI

Current developments of coumarin-based anti-cancer agents in medicinal chemistry

TL;DR: The current developments of coumarin-based anticancer agents are covered and the structure-activity relationship of the most potent compounds are discussed.
Journal ArticleDOI

Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms.

TL;DR: The present article aims to review the current application of indole core in the design of new anticancer agents that may act via various targets such as histone deacetylases, sirtuins, PIM kinases, DNA topoisomerases and σ receptors.
Journal ArticleDOI

Microwave-assisted synthesis and anticonvulsant activity of 5,6-bisaryl-1,2,4-triazine-3-thiol derivatives

TL;DR: A series of 5,6-bisaryl-1,2,4-triazine-3-thiol derivatives were synthesized through microwave-promoted chemistry by condensation of the aromatic 1,2-diketones and thiosemicarbazide in a mixed green solvent.
Journal ArticleDOI

Design, Synthesis and In Vitro Study of 5,6-Diaryl-1,2,4-triazine-3-ylthioacetate Derivatives as COX-2 and β-Amyloid Aggregation Inhibitors

TL;DR: In order to find novel cyclooxygenase (COX)‐2 inhibitors for treating inflammatory‐based diseases such as Alzheimer's disease, an ethyl carboxylate side chain was added to 5‐(4‐chlorophenyl)‐6‐(3‐methylsulfonyl)‐3‐(methylthio)‐1,2,4‐triazine (lead compound II) to maintain residual inhibition of COX‐1 through interacting with Arg120.
Journal ArticleDOI

1,2‐Diaryl‐2‐hydroxyiminoethanones as Dual COX‐1 and β‐Amyloid Aggregation Inhibitors: Biological Evaluation and In Silico Study

TL;DR: Conformational study of compound 3 and subsequent docking of its restrained analogs on both active sites of COX‐1 andCOX‐2 could provide a proof of its COX•1 selectivity as well as molecular dynamic simulation could elucidate and give more insight into the amyloid disaggregation mechanisms leading to rational design of inhibitors.